Inventor · disambiguated record
Marta Dabros
Also filed as: DABROS MARTA
14 granted patents·6 pending applications·101 citations·filing 2007–2023
92Inventor score
Top patents by PatentIndex Score
20 records- 0197US10183942B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jan 22, 2019·23 cites·6 claims
- 0296US10493077B2Fused imidazo-piperidine JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Dec 3, 2019·14 cites·19 claims
- 0396US10308646B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jun 4, 2019·11 cites·32 claims
- 0495US10251874B2Crystalline forms of a JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Apr 9, 2019·23 cites·23 claims
- 0594US10913740B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 9, 2021·5 cites·18 claims
- 0688US12172994B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 0788US9115054B2Tetrahydronaphthalenyl compounds useful as sipi agonistsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 25, 2015·13 cites·20 claims
- 0887US10538513B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Jan 21, 2020·4 cites·16 claims
- 0985US10392368B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 27, 2019·5 cites·46 claims
- 1083US10968205B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Apr 6, 2021·1 cites·26 claims
- 1182US11814377B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Nov 14, 2023·0 cites·19 claims
- 1282US11160810B2Fused imidazo-piperidine JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Nov 2, 2021·2 cites·27 claims
- 1379US11718616B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Aug 8, 2023·0 cites·7 claims
- 1470US2022119369A1Pyrazolo and triazolo bicyclic compounds as jak kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Application pending·0 cites
- 1562US2016318904A1Substituted tetrahydroisoquinoline compounds as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1652US2024190845A1Crystal forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1752US2021387983A1Crystalline alk5 inhibitors and uses thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Application pending·0 cites
- 1851US9920034B2Crystalline forms of a factor XIa inhibitorBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 20, 2018·0 cites·19 claims
- 1949US2022306626A1Crystalline form of a dihydrochloride salt of a jak inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
- 2047US2011009623A1Selective growth of stable polymorphsWORCESTER POLYTECH INST·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marta Dabros files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →